Clinical Trials Directory

Trials / Completed

CompletedNCT01282281

Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder

Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder.

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Dr. Ayal Schaffer · Academic / Other
Sex
All
Age
14 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Background: Most psychotropic medications that are effective in the treatment of Bipolar Disorder (BD) are associated with endocrine-metabolic changes (EMCs). To date, there is no long-term study in BD that has examined specifically the association of inflammation with EMCs in BD. Specific aims: 1) to identify predictors of EMCs among adolescents and adults with BD who are being started on a medication ; 2) to compare change in EMCs in youth and adults treated for BD; 3) to measure change in EMCs associated with use of different medications for BD. Research Design: Participants: 30 adolescents (14-18 years old) with BD and 30 adults (19-65 years old) with BD. Measures: Blood levels of biomarkers that are associated with EMCs will be measured.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2013-01-01
Completion
2013-09-01
First posted
2011-01-24
Last updated
2014-01-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01282281. Inclusion in this directory is not an endorsement.